FI103116B1 - Menetelmä uusien, terapeuttisesti käyttökelpoisten, N-substituoitujen atsaheterosyklisten karboksyylihappojohdannaisten valmistamiseksi - Google Patents
Menetelmä uusien, terapeuttisesti käyttökelpoisten, N-substituoitujen atsaheterosyklisten karboksyylihappojohdannaisten valmistamiseksiInfo
- Publication number
- FI103116B1 FI103116B1 FI935064A FI935064A FI103116B1 FI 103116 B1 FI103116 B1 FI 103116B1 FI 935064 A FI935064 A FI 935064A FI 935064 A FI935064 A FI 935064A FI 103116 B1 FI103116 B1 FI 103116B1
- Authority
- FI
- Finland
- Prior art keywords
- preparation
- carboxylic acid
- acid derivatives
- therapeutically useful
- novel therapeutically
- Prior art date
Links
- 150000001732 carboxylic acid derivatives Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 abstract 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Hydrogenated Pyridines (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK91937A DK93791D0 (da) | 1991-05-17 | 1991-05-17 | Nye heterocykliske carboxylsyrer |
| DK93791 | 1991-05-17 | ||
| PCT/DK1992/000155 WO1992020658A1 (en) | 1991-05-17 | 1992-05-14 | Novel heterocyclic carboxylic acids |
| DK9200155 | 1992-05-14 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI935064A0 FI935064A0 (fi) | 1993-11-16 |
| FI935064L FI935064L (fi) | 1993-11-16 |
| FI103116B FI103116B (fi) | 1999-04-30 |
| FI103116B1 true FI103116B1 (fi) | 1999-04-30 |
Family
ID=8099201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI935064A FI103116B1 (fi) | 1991-05-17 | 1993-11-16 | Menetelmä uusien, terapeuttisesti käyttökelpoisten, N-substituoitujen atsaheterosyklisten karboksyylihappojohdannaisten valmistamiseksi |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5348965A (enExample) |
| EP (1) | EP0585314B1 (enExample) |
| JP (1) | JPH06507616A (enExample) |
| AT (1) | ATE143009T1 (enExample) |
| AU (1) | AU665761B2 (enExample) |
| CA (1) | CA2102811A1 (enExample) |
| DE (1) | DE69213935T2 (enExample) |
| DK (2) | DK93791D0 (enExample) |
| ES (1) | ES2094357T3 (enExample) |
| FI (1) | FI103116B1 (enExample) |
| GR (1) | GR3021822T3 (enExample) |
| IL (1) | IL101887A (enExample) |
| NO (1) | NO300211B1 (enExample) |
| NZ (1) | NZ242759A (enExample) |
| WO (1) | WO1992020658A1 (enExample) |
| ZA (1) | ZA923556B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK74393D0 (da) * | 1993-06-23 | 1993-06-23 | Novo Nordisk As | Novel heterocyclic chemistry |
| DK74693D0 (da) * | 1993-06-23 | 1993-06-23 | Novo Nordisk As | Novel heterocyclic chemistry |
| DK74493D0 (da) * | 1993-06-23 | 1993-06-23 | Novo Nordisk As | Novel heterocyclic chemistry |
| IL112223A0 (en) * | 1994-01-04 | 1995-03-30 | Novo Nordisk As | Pharmaceutical compositions for the treatment of neurological inflammatory conditions |
| US5698551A (en) * | 1995-04-07 | 1997-12-16 | Novo Nordisk A/S | Heterocyclic compounds |
| US5962449A (en) | 1995-04-07 | 1999-10-05 | Novo Nordisk A/S | Tricyclic compounds in treating hyperalgesic conditions and NIDDM |
| WO1997022342A1 (en) * | 1995-12-15 | 1997-06-26 | Novo Nordisk A/S | Novel method |
| AU7907298A (en) * | 1997-06-25 | 1999-01-19 | Novo Nordisk A/S | Novel heterocyclic compounds |
| IE970588A1 (en) | 1997-08-01 | 2000-08-23 | Elan Corp Plc | Controlled release pharmaceutical compositions containing tiagabine |
| US6468996B1 (en) * | 1998-10-21 | 2002-10-22 | Novo Nordisk A/S | Substituted hetero-polycyclic compounds as PPARα and PPARγ activators |
| CN1382441A (zh) * | 2002-05-21 | 2002-12-04 | 中国科学院上海生命科学研究院 | γ－氨基丁酸转运蛋白抑制剂在制备镇痛药物中的应用 |
| US7378426B2 (en) * | 2004-03-01 | 2008-05-27 | Bristol-Myers Squibb Company | Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3 |
| US7417040B2 (en) * | 2004-03-01 | 2008-08-26 | Bristol-Myers Squibb Company | Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL99690C (enExample) * | 1956-11-15 | |||
| BE560750A (enExample) * | 1957-07-26 | |||
| CH368178A (de) * | 1958-09-10 | 1963-03-31 | Geigy Ag J R | Verfahren zur Herstellung von neuen basisch substituierten heterocyclischen Verbindungen |
| DK704488D0 (da) * | 1988-12-19 | 1988-12-19 | Novo Industri As | Nye n-substituerede azaheterocykliske carboxylsyrer |
| FI864246A7 (fi) * | 1985-11-08 | 1987-05-09 | Warner Lambert Co | N-substituerade 3-piperidin- eller 3-pyridinkarboxylsyror samt deras derivat. |
| US4910312A (en) * | 1985-11-08 | 1990-03-20 | Warner-Lambert Company | Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof |
| DK270488D0 (da) * | 1988-05-18 | 1988-05-18 | Novo Industri As | Hidtil ukendte o-substituerede ketoximer |
-
1991
- 1991-05-17 DK DK91937A patent/DK93791D0/da not_active Application Discontinuation
-
1992
- 1992-05-14 JP JP4509775A patent/JPH06507616A/ja active Pending
- 1992-05-14 AU AU17837/92A patent/AU665761B2/en not_active Ceased
- 1992-05-14 CA CA2102811A patent/CA2102811A1/en not_active Abandoned
- 1992-05-14 ES ES92910899T patent/ES2094357T3/es not_active Expired - Lifetime
- 1992-05-14 EP EP92910899A patent/EP0585314B1/en not_active Expired - Lifetime
- 1992-05-14 DE DE69213935T patent/DE69213935T2/de not_active Expired - Fee Related
- 1992-05-14 AT AT92910899T patent/ATE143009T1/de not_active IP Right Cessation
- 1992-05-14 DK DK92910899.1T patent/DK0585314T3/da active
- 1992-05-14 WO PCT/DK1992/000155 patent/WO1992020658A1/en not_active Ceased
- 1992-05-14 US US07/882,788 patent/US5348965A/en not_active Expired - Fee Related
- 1992-05-15 NZ NZ242759A patent/NZ242759A/en unknown
- 1992-05-15 ZA ZA923556A patent/ZA923556B/xx unknown
- 1992-05-15 IL IL10188792A patent/IL101887A/en not_active IP Right Cessation
-
1993
- 1993-11-16 FI FI935064A patent/FI103116B1/fi active
- 1993-11-17 NO NO934159A patent/NO300211B1/no not_active IP Right Cessation
-
1996
- 1996-11-28 GR GR960403213T patent/GR3021822T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0585314B1 (en) | 1996-09-18 |
| DK93791D0 (da) | 1991-05-17 |
| JPH06507616A (ja) | 1994-09-01 |
| ES2094357T3 (es) | 1997-01-16 |
| NO934159D0 (no) | 1993-11-17 |
| IL101887A0 (en) | 1992-12-30 |
| ZA923556B (en) | 1993-01-27 |
| US5348965A (en) | 1994-09-20 |
| GR3021822T3 (en) | 1997-02-28 |
| DE69213935D1 (en) | 1996-10-24 |
| FI103116B (fi) | 1999-04-30 |
| WO1992020658A1 (en) | 1992-11-26 |
| NZ242759A (en) | 1995-03-28 |
| AU1783792A (en) | 1992-12-30 |
| DE69213935T2 (de) | 1997-03-27 |
| NO300211B1 (no) | 1997-04-28 |
| IL101887A (en) | 1996-10-16 |
| CA2102811A1 (en) | 1992-11-26 |
| FI935064A0 (fi) | 1993-11-16 |
| DK0585314T3 (enExample) | 1997-05-05 |
| ATE143009T1 (de) | 1996-10-15 |
| EP0585314A1 (en) | 1994-03-09 |
| AU665761B2 (en) | 1996-01-18 |
| NO934159L (no) | 1993-11-17 |
| FI935064L (fi) | 1993-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA29450C2 (uk) | Похідні гідроксамової кислоти, спосіб їх одержання, спосіб впливу на хвороби та фармацевтична або ветеринарна композиція, що їх містить | |
| FI103116B1 (fi) | Menetelmä uusien, terapeuttisesti käyttökelpoisten, N-substituoitujen atsaheterosyklisten karboksyylihappojohdannaisten valmistamiseksi | |
| DK0495982T3 (da) | Bicyklisk pyrimidinderivat, fremgangsmåde til fremstilling deraf og farmaceutisk præparat omfattende dette som en aktiv bestanddel | |
| RU94040864A (ru) | Конденсированные индольные производные, их получение, фармацевтическая композиция | |
| GEP20012413B (en) | Novel Substituted Cyclic Amino Acids as Pharmaceutical Agents | |
| ATE73657T1 (de) | Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose. | |
| EP0696208A4 (en) | ORAL DELIVERY FORM AND METHOD | |
| UA41446C2 (uk) | Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі | |
| FR2674524B1 (fr) | Nouveaux amides alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. | |
| DE69510928D1 (de) | Heterocyclische verbindungen, ihre herstellung und verwendung | |
| FI884375A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten N-(1-alkyyli-3-hydroksi-4-piperidinyyli)bentsamidien valmistamiseksi | |
| FI894899A0 (fi) | Menetelmä dispergoituvan kiinteän lääkeainekoostumuksen valmistamiseksi | |
| ATE85523T1 (de) | Taurohyodeoxycholsaeure zur behandlung von gallenwegssteinen und gallenstoerungen. | |
| HUT49603A (en) | Process for producing tetrazole derivatives and pharmaceutical compositions comprising same | |
| AU590172B2 (en) | Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof | |
| MX9403088A (es) | Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso. | |
| IL109076A0 (en) | Imidazolo-quinoxalinones, their preparation and pharmaceutical compositions containing them | |
| ES2182975T3 (es) | Nueva quimica heterociclica. | |
| BG100246A (en) | N-substituted azaheterocylic carboxylic acids and their esters | |
| GR3020575T3 (en) | New 2-amino-5-cyano-1,4-dihydropyridines, process for their preparation and use in pharmaceutical compositions | |
| GEP20032929B (en) | 6-O-Methyl-Erythromycin A Class, Novel 8a-and 9a-15-Membered Lactams, Method for Their Production and Pharmaceutical Composition for Treatment of Bacterial Infections | |
| AU2287197A (en) | Heterocyclic compounds and their preparation and use | |
| MX9704704A (es) | Amidas de acido 4-amino-2-ureido-pirimidin-5-carboxilico, procedimientos para su obtencion, medicamentos que contienen estos compuestos, y su utilizacion. | |
| DK0986390T3 (da) | Farmaceutiske præparater med cinchosin-dihydrochlorid | |
| BG100244A (en) | N-substituted azaheterocyclic carboxylic acids and their esters |